Correlation between Serum RANTES Levels and the Severity of Parkinson’s Disease
Inflammatory mediators may reflect a role of systemic inflammation in the neurodegenerative process of Parkinson’s disease (PD). Interleukin-6 (IL-6) and chemokine ligand 5 (CCL5), also known as RANTES (regulated on activation, normal T cell expressed and secreted), have been implicated in neurodege...
Main Authors: | Peng Tang, Li Chong, Xiaoqing Li, Yue Liu, Peng Liu, Chen Hou, Rui Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2014-01-01
|
Series: | Oxidative Medicine and Cellular Longevity |
Online Access: | http://dx.doi.org/10.1155/2014/208408 |
Similar Items
-
Levels of RANTES, Eotaxin in the patients with chronic rhinosinusitis and its correlation with severity of the disease
by: Pin-Zhir Chao, et al.
Published: (2004) -
Effect of levodopa on interleukin-15 and RANTES circulating levels in patients affected by Parkinson's disease
by: Sebastiano Gangemi, et al.
Published: (2003-01-01) -
Plasma RANTES level is correlated with cardio-cerebral atherosclerosis burden in patients with ischemic cerebrovascular disease
by: Qi Kong, et al.
Published: (2020-03-01) -
Correlation between serum renin-angiotensin system (RAS) level and depression and anxiety symptoms in patients with Parkinson's disease
by: ChongChong Zhao, et al.
Published: (2021-04-01) -
Evaluation of serum chemokine RANTES concentration as a biomarker in the diagnosis of early-onset severe infections in neonates
by: Małgorzata Stojewska, et al.
Published: (2016-04-01)